Advanced search
Publication Cover
Pharmacogenomics Volume 25, 2024 - Issue 4
Submit an article Journal homepage
525
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization

Yael Bar-Peled1 Department of Clinical & Diagnostic Sciences, University of Alabama at Birmingham, AL35294, USAORCID Iconhttps://orcid.org/0000-0002-4904-5571
ORCID Icon,
Jessica J Denton1 Department of Clinical & Diagnostic Sciences, University of Alabama at Birmingham, AL35294, USAORCID Iconhttps://orcid.org/0000-0002-4229-839X
ORCID Icon,
Jaimie L Richards2 Department of Preventive Medicine, University of Alabama at Birmingham, AL35294, USA;3 Department of Genetics & Pediatrics, University of Alabama at Birmingham Heersink School of Medicine, AL35294, USAORCID Iconhttps://orcid.org/0000-0003-3596-8284
ORCID Icon,
Donna Brown3 Department of Genetics & Pediatrics, University of Alabama at Birmingham Heersink School of Medicine, AL35294, USAORCID Iconhttps://orcid.org/0000-0002-8805-7225
ORCID Icon,
Elizabeth Worthey3 Department of Genetics & Pediatrics, University of Alabama at Birmingham Heersink School of Medicine, AL35294, USAORCID Iconhttps://orcid.org/0000-0003-4083-7764
ORCID Icon &
Theresa V Strong4 Department of Genetics, University of Alabama at Birmingham Heersink School of Medicine, AL35294, USA;5 Foundation for Prader-Willi Research, Covina, CA91723, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6783-8703
ORCID Icon
Pages 207-216 | Received 01 Oct 2023, Accepted 29 Feb 2024, Published online: 20 Mar 2024

References

  • Schmidlen T , SturmAC , ScheinfeldtLB. Pharmacogenomic (PGx) counseling: exploring participant questions about PGx test results. J. Pers. Med.10(2), 29 (2020).
  • Patton K , BorshoffDC. Adverse drug reactions. Anaesthesia73, 76–84 (2018).
  • Unertl KM , JaffaH , FieldJR , PriceL , PetersonJF. Clinician perspectives on using pharmacogenomics in clinical practice. Per. Med.12(4), 339–347 (2015).
  • Peterson JF , FieldJR , ShiYet al. Attitudes of clinicians following large-scale pharmacogenomics implementation. Pharmacogenomics J.16(4), 393–398 (2016).
  • Borden BA , GaleckiP , WellmannRet al. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study. Pharmacogenet. Genomics29(2), 31–38 (2019).
  • Haga SB , LiuY. Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory. Pharmacogenomics20(8), 581–587 (2019).
  • Olson JE , RohrerVitek CR , BellEJet al. Participant-perceived understanding and perspectives on pharmacogenomics: the Mayo Clinic RIGHT protocol. Genet. Med.19(7), 819–825 (2017).
  • Forster J , DuisJ , ButlerMG. Pharmacogenetic testing of cytochrome p450 drug metabolizing enzymes in a case series of patients with Prader-Willi syndrome. Genes (Basel)12(2), 152 (2021).
  • Bohonowych J , MillerJ , McCandlessSE , StrongTV. The Global Prader-Willi Syndrome Registry: development, launch, and early demographics. Genes10(9), 713 (2019).
  • Butler MG , MillerJL , ForsterJL. Prader-Willi syndrome - clinical genetics, diagnosis and treatment approaches: an update. Curr. Pediatr. Rev.15(4), 207–244 (2019).
  • Kim SJ , ChoSY , JinDK. Prader-Willi syndrome: an update on obesity and endocrine problems. Ann. Pediatr. Endocrinol. Metab.26(4), 227–236 (2021).
  • Bonnot O , CohenD , ThuilleauxD , ConsoliA , CabalS , TauberM. Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature. Eur. J. Pediatr.175(1), 9–18 (2016).
  • Raj R , OwenD , KannanL , SyedaU. Polypharmacy in a patient with intellectual and developmental disabilities. Cureus14(2), e22019 (2022).
  • Forster J , DuisJ , ButlerMG. Pharmacodynamic gene testing in Prader-Willi syndrome. Front. Genet.11, 579609 (2020).
  • Bielinski SJ , StSauver JL , OlsonJEet al. Are patients willing to incur out-of-pocket costs for pharmacogenomic testing? Pharmacogenomics J. 17(1), 1–3 (2017).
  • Lemke AA , HulickPJ , WakeDTet al. Patient perspectives following pharmacogenomics results disclosure in an integrated health system. Pharmacogenomics19(4), 321–331 (2018).
  • Stancil SL , BerriosC , Abdel-RahmanS. Adolescent perceptions of pharmacogenetic testing. Pharmacogenomics22(6), 335–343 (2021).
  • Virelli CR , MohiuddinAG , KennedyJL. Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis. Transl. Psychiatr.11(1), 509 (2021).
  • Erdmann A , Rehmann-SutterC , BozzaroC. Patients’ and professionals’ views related to ethical issues in precision medicine: a mixed research synthesis. BMC Med. Ethics22(1), 116 (2021).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.